NCT05694715
- Conditions
- ATM Gene Mutation, BRCA1 Mutation, BRCA2 Mutation, +7 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
ATM Gene Mutation
Explore clinical trials studying ATM Gene Mutation. Study availability and eligibility vary by location and protocol.
10 public trials
5 recruiting studies
ATM Gene Mutation trial results
Recruiting
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors
NCT06177171
- Conditions
- ATM Gene Mutation, BRCA Mutation, BRCA1 Mutation, +3 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT05097274
- Conditions
- ATM Gene Mutation, BRCA Mutation, CHEK2 Gene Mutation, +14 more
- Locations
-
- Cancer Genetics Unit, Royal Marsden Hospital London, Sutton, Surrey, United Kingdom
- Conditions
- APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activity) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT05129605
- Conditions
- ATM Gene Mutation, BRCA1 Mutation, BRCA2 Mutation, +35 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT03962114
- Conditions
- ATM Gene Mutation, Ataxia, Ataxia Telangiectasia, +28 more
- Locations
-
- Radboudumc Nijmegen, Netherlands
NCT03377556
- Conditions
- ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
NCT02286687
- Conditions
- ATM Gene Mutation, Advanced Malignant Neoplasm, BRCA1 Gene Mutation, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Olaparib In Metastatic Breast Cancer
NCT03344965
- Conditions
- ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Chicago, Illinois, United States
- Indiana University Indianapolis, Indiana, United States
Active, Not Recruiting
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092
- Conditions
- ATM Gene Mutation, Adenocarcinoma, BRCA Mutation, +20 more
- Locations
-
- E.O. Galliera Genoa, Italy
- Istituto Europeo di Oncologia Milan, Italy
- Istituto Nazionale Tumori G. Pascale Naples, Italy
- Istituto Oncologico Veneto Padova, Italy